Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
2010 · New England Journal of Medicine · 15K citations
https://doi.org/10.1056/nejmoa1003466
G
Gerald P. Linette
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
252
Papers
41.7K
Citations
59
h-index
122
i10-index
Gerald P. Linette is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Melanoma and MAPK Pathways. The author has an h-index of 59, co-authored 215 publications.
ORCID: 0000-0001-6147-6115Papers by this author
worksIdentification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells
2013 · Science Translational Medicine · 660 citations
https://doi.org/10.1126/scitranslmed.3006034
pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
2016 · Genome Medicine · 499 citations
https://doi.org/10.1186/s13073-016-0264-5
Targeted Therapy in Breast Cancer
2004 · Molecular & Cellular Proteomics · 303 citations
https://doi.org/10.1074/mcp.r400001-mcp200
Induction of anti-HIV neutralizing antibodies by synthetic peptides.
1986 · The EMBO Journal · 227 citations
https://doi.org/10.1002/j.1460-2075.1986.tb04607.x
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
2021 · Nature Communications · 108 citations
https://doi.org/10.1038/s41467-021-24562-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat